Image

Characterization of Exosomes Platelets-released

Characterization of Exosomes Platelets-released

Recruiting
20-60 years
All
Phase N/A

Powered by AI

Overview

Extracellular vesicles (EVs) play a key role in cell-to-cell communication. They are small vesicles that contain rich molecular cargo. Recently, they have been proposed as biomarkers for clinical diagnostics. EVs include three classes: small EVs (exosomes), large EVs (microparticles), and apoptotic bodies. Platelet-derived EVs (PEVs) are the most abundant class in human blood and can actively participate in numerous physiological and pathological processes. The information about the role of platelet exosomes in cardiovascular disease and the effect of antiplatelet agents on their release and content is very limited.

Description

This study is a multicentre, observational. We plan to enrol 54 subjects from Centro Cardiologico Monzino IRCCS, and 121 buffy coat related to 121 subjects from Centro Trasfusionale Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. biographical and anthropomorphic data will be recorded, a fasting blood venous sample (from ante-cubital vein) will be collected for the haematochemical analyses and for research samples.

Eligibility

Inclusion Criteria:

  • subjects without known pathologies

Exclusion Criteria:

  • individuals with gastrointestinal diseases,
  • individuals with history of hepatic diseases,
  • individuals with history of urogenital diseases,
  • individuals with history of hematological diseases,
  • individuals with history of immunological diseases,
  • individuals with history of renal diseases,
  • individuals with history of metabolic diseases
  • individuals with history of respiratory diseases
  • individuals with history of cancer
  • individuals with history of cardiovascular disease
  • individuals having permanent organ damage
  • individuals with major trauma in the last 6 months prior to enrollment
  • individuals with surgery in the last 6 months prior to enrollment
  • individuals taking medication in the 15 days prior to enrolment.

Study details
    Platelet Thrombus

NCT06298682

Centro Cardiologico Monzino

22 March 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.